Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
Clinical trial NCT06356129 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06356129
- Sponsor
- Celgene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2027-08-09
- Enrollment
- 850
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.